Developmental Outcomes of Extreme Prematurity, 5-15 Years Postpartum
NCT ID: NCT01430832
Last Updated: 2018-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
95 participants
OBSERVATIONAL
2011-09-01
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interdisciplinary E-health Based Follow-up of Preterm Born Children
NCT06345664
Transition to Home (TtH) After Preterm Birth
NCT03460496
Impact of an Intervention Program on Parenting Stress After Preterm Birth
NCT02394444
Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year
NCT00550069
Monitoring Growth of Preterm Infants
NCT01869153
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal Development
The infant's development level will be assessed using a phone interview with parents
No interventions assigned to this group
Abnormal Development
The infant's level of development will be assessed using a phone interview with parents
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Very low birth weight or extremely low birth weight
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lidia Gabis, MD
Role: PRINCIPAL_INVESTIGATOR
Sheba Medical Center
Gabi Zerach, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Ariel University
Shefer Shahar, Ph.D
Role: STUDY_DIRECTOR
Sheba Medical Center
Adi Elsing, BA
Role: STUDY_DIRECTOR
Sheba Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sheba Medical Center
Ramat Gan, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-10-8121-LG-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.